Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) involves the accumulation of abnormal B-cells.
• The exact normal cell type from which CLL originates is still debated.
• CLL B-cells exhibit a highly uniform phenotype and gene expression profile.

Purpose of the Study:

• To review current knowledge on peripheral B-cell differentiation and human B-cell subsets.
• To explore functional characteristics of CLL B-cells to identify potential normal cellular counterparts.
• To discuss the criteria for defining the normal counterpart of CLL B-cells.

Main Methods:

• Review of immunophenotypic and molecular data (gene mutational status, transcriptional, epigenetic profiling).
• Analysis of functional characteristics of CLL B-cells, including activation and differentiation.
• Comparison of functional features between normal B-cell subsets and CLL B-cells.

Main Results:

• Recent insights have improved understanding of CLL biology and natural history.
• Functional analysis reveals differences among B-cell subsets.
• Shared functional characteristics suggest potential, but not definitive, normal cellular counterparts for CLL B-cells.

Conclusions:

• A definitive normal cellular counterpart for CLL B-cells cannot be established with current data.
• Further investigation into functional characteristics is needed to logically assign a normal counterpart.
• Understanding the normal counterpart is crucial for a comprehensive understanding of CLL pathogenesis.